1 - 10 of 40 articles
Key PointsQuestionDoes the addition of metformin hydrochloride to standard epidermal growth factor receptor (EGFR)–tyrosine kinase inhibitors for EGFR-mutated lung adenocarcinoma improve progression-free survival compared with EGFR–tyrosine kinase inhibitors therapy alone?
FindingsIn this phase...
This Patient Page describes antibody drug conjugates and their roles in cancer treatment.
This Viewpoint suggests a strategy to provide breakthrough cancer drugs to patients in lower-income countries for much lower costs while not disincentivizing pharmaceutical innovation.
In this essay, the author reflects on lessons learned from a patient with metastatic lung cancer who wanted to have a baby.
Read and print from thousands of top scholarly journals.
Continue with Facebook
Sign up with Google
Log in with Microsoft
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.